CTOs on the Move


 
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kapost.com
  • 1800 Broadway Suite 180
    Boulder, CO USA 80302
  • Phone: 720.408.0222

Executives

Name Title Contact Details

Funding

Kapost raised $10M on 05/13/2015

Similar Companies

Sertainty

Sertainty enables developers to mix intelligence into data files for active risk mitigation and data control. Discover the impact of Data: Empowered.

OneStreet Res

At OneStreet Residential, we dont just build communities. We build a step up into the next chapter of your life. Our neighborhoods keep you at the center of your city, with close proximity to area attractions, transportation, and shopping. Join the On...

FileHold Systems

Document Management and Record Management Software that is enterprise grade. FileHold makes documents and records secure compliant and searchable.

echogravity

echogravity delivers custom outsourced marketing for staffing and recruiting firms. We are experts in content strategy and staffing websites.

Centaur Academic Media

Centaur Academic Media is a San Francisco, CA-based company in the Software and Internet sector.